Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CH.1.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.237EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBNEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.356EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.462EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.147EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.6 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.5 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.4 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.420EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.39.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.233EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.320EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.635EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.19 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.15 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.113EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.423EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.83EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.2.4 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.161EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.75EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.411EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.217EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.17 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used